Biology: How Nanoparticles Exploit Surface Area

Nanotechnology is transforming medicine by exploiting a fundamental principle of cell biology: as a particle's size decreases, its surface area to volume ratio (SA:V) increases dramatically. Nanoparticles engineered for drug delivery therefore release their payload far more rapidly than conventional particles, allowing chemotherapy to be concentrated directly at tumour sites while sparing healthy tissue. This targeted approach reduces side effects such as nausea, hair loss and immune suppression, improving patient quality of life — yet its high manufacturing cost raises concerns about unequal access and widening healthcare disparities. The same properties that make nanoparticles effective therapeutically also create environmental risks. Excreted or improperly disposed nanoparticles are small enough to pass through conventional water-treatment filters, persisting in waterways where they may be absorbed by microorganisms and bioaccumulate through successive trophic levels, reaching toxic concentrations in fish. At the cellular level, they can disrupt membrane function, linking human health, ecological stability and economic equity into one interconnected challenge.